%0 Journal Article %T Adverse events with bioresorbable vascular scaffolds in routine percutaneous coronary interventions: “coup de théâtre” or unfinished play? %A Cassese, Salvatore %A Husser, Oliver %A Kastrati, Adnan %J Journal of Thoracic Disease %D 2017 %B 2017 %9 %! Adverse events with bioresorbable vascular scaffolds in routine percutaneous coronary interventions: “coup de théâtre” or unfinished play? %K %X Bioresorbable scaffolds are percutaneous coronary prostheses designed to ensure transient support of the dilated vessel and dissolution into inert breakdown products overtime (1). By leaving the coronary artery without a permanent metallic implant, bioresorbable scaffolds have been developed to absolve three main commitments: improve long-term vessel healing and remodelling, restore vasomotor function of the treated segment, and reduce the burden of angina symptoms in comparison with conventional drug-eluting stent (DES) platforms. %U https://jtd.amegroups.org/article/view/14897 %V 9 %N 8 %P 2303-2307 %@ 2077-6624